BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32211219)

  • 1. Assessing bladder hyper-permeability biomarkers
    Towner RA; Smith N; Saunders D; Lerner M; Greenwood-Van Meerveld B; Hurst RE
    Am J Nucl Med Mol Imaging; 2020; 10(1):57-65. PubMed ID: 32211219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis.
    Smith N; Saunders D; Lerner M; Zalles M; Mamedova N; Cheong D; Mohammadi E; Yuan T; Luo Y; Hurst RE; Greenwood-Van Meerveld B; Towner RA
    PLoS One; 2020; 15(10):e0239282. PubMed ID: 33095778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies.
    Towner RA; Smith N; Saunders D; Hurst RE
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor.
    Boucher W; Kempuraj D; Michaelian M; Theoharides TC
    BJU Int; 2010 Nov; 106(9):1394-9. PubMed ID: 20201838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SuperGAG biopolymers for treatment of excessive bladder permeability.
    Towner RA; Greenwood-Van Meerveld B; Mohammadi E; Saunders D; Smith N; Sant GR; Shain HC; Jozefiak TH; Hurst RE
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00709. PubMed ID: 33540486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
    Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients.
    Saban R; Saban MR; Maier J; Fowler B; Tengowski M; Davis CA; Wu XR; Culkin DJ; Hauser P; Backer J; Hurst RE
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1613-23. PubMed ID: 18815217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.
    Towner RA; Smith N; Saunders D; Van Gordon SB; Wisniewski AB; Tyler KR; Greenwood-Van Meerveld B; Hurst RE
    J Urol; 2015 Apr; 193(4):1394-400. PubMed ID: 25463988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.
    Jhang JF; Kuo HC
    Int Neurourol J; 2016 Nov; 20(Suppl 2):S95-104. PubMed ID: 27915472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
    Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
    Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis.
    Zhao J; Wang L; Dong X; Hu X; Zhou L; Liu Q; Song B; Wu Q; Li L
    Sci Rep; 2016 Feb; 6():19670. PubMed ID: 26883396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants of afferent sensitization in a rat model of cystitis with urothelial barrier dysfunction.
    Montalbetti N; Rooney JG; Rued AC; Carattino MD
    J Neurophysiol; 2019 Sep; 122(3):1136-1146. PubMed ID: 31314637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome.
    Lee JD; Lee MH
    J Formos Med Assoc; 2014 Jan; 113(1):17-22. PubMed ID: 24445008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.
    Greenwood-Van Meerveld B; Mohammadi E; Latorre R; Truitt ER; Jay GD; Sullivan BD; Schmidt TA; Smith N; Saunders D; Ziegler J; Lerner M; Hurst R; Towner RA
    Urology; 2018 Jun; 116():230.e1-230.e7. PubMed ID: 29545038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations.
    Kiuchi H; Tsujimura A; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Nonomura N; Takeyama M; Okuyama A
    BJU Int; 2009 Sep; 104(6):826-31; discussion 831. PubMed ID: 19298410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
    Peng CH; Jhang JF; Shie JH; Kuo HC
    Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in Expression of Structural, Barrier and Differentiation Related Proteins, and Chondroitin Sulfate in Feline and Human Interstitial Cystitis.
    Hauser PJ; VanGordon SB; Seavey J; Sofinowski TM; Ramadan M; Abdullah S; Buffington CA; Hurst RE
    J Urol; 2015 Aug; 194(2):571-7. PubMed ID: 25636658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.
    Slobodov G; Feloney M; Gran C; Kyker KD; Hurst RE; Culkin DJ
    J Urol; 2004 Apr; 171(4):1554-8. PubMed ID: 15017219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
    Jhang JF; Hsu YH; Kuo HC
    Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis.
    Wyndaele JJJ; Riedl C; Taneja R; Lovász S; Ueda T; Cervigni M
    Neurourol Urodyn; 2019 Feb; 38(2):535-544. PubMed ID: 30592544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.